相似文献
1
Clinical response and plasma levels of 5-fluorouracil in patients with colonic cancer treated by drug infusion.
Br J Cancer. 1978 Dec;38(6):719-24. doi: 10.1038/bjc.1978.278.
2
Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
Cancer Treat Rep. 1976 Jun;60(6):733-7.
3
Combination chemotherapy with 5-fluorouracil and methyl-CCNU for the treatment of advanced gastrointestinal cancer.
Tumori. 1979 Jun 30;65(3):339-44. doi: 10.1177/030089167906500309.
4
Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel.
Cancer Treat Rep. 1977 Nov;61(8):1453-8.
5
5FU infusion with mitomycin-C versus 5 FU infusion with methyl-CCNU in the treatment of advanced colon cancer: a Southwest Oncology Group Study.
Cancer. 1978 Sep;42(3):1228-33. doi: 10.1002/1097-0142(197809)42:3<1228::aid-cncr2820420330>3.0.co;2-s.
6
Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.
Cancer Treat Rep. 1976 Jun;60(6):769-80.
7
Treatment of advanced colorectal cancer with a combination of 5-fluorouracil and methyl-CCNU.
Med Pediatr Oncol. 1978;4(3):277-8. doi: 10.1002/mpo.2950040312.
8
Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study.
Cancer. 1976 Jul;38(1):1-7. doi: 10.1002/1097-0142(197607)38:1<1::aid-cncr2820380102>3.0.co;2-s.
9
A controlled study of 5-fluorouracil versus 5-fluorouracil and methyl-CCNU in advanced gastrointestinal adenocarcinoma.
Clin Oncol. 1977 Sep;3(3):247-57.
10
Combination of constant-infusion 5-fluorouracil, methyl-CCNU, mitomycin C, and vincristine in advanced colorectal carcinoma.
Cancer Treat Rep. 1978 Sep;62(9):1407-8.
引用本文的文献
1
Therapeutic drug monitoring for cytotoxic anticancer drugs: Principles and evidence-based practices.
Front Oncol. 2022 Dec 8;12:1015200. doi: 10.3389/fonc.2022.1015200. eCollection 2022.
2
High-dose chemotherapy for relapsed testicular germ cell tumours.
Nat Rev Urol. 2023 Apr;20(4):217-225. doi: 10.1038/s41585-022-00683-1. Epub 2022 Dec 7.
3
and Fluorouracil-Based Chemotherapy: Mini Review and Case Report.
Pharmaceutics. 2019 May 1;11(5):199. doi: 10.3390/pharmaceutics11050199.
4
Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5-Fluorouracil Therapy.
Clin Pharmacol Ther. 2019 Mar;105(3):598-613. doi: 10.1002/cpt.1124. Epub 2018 Sep 11.
5
Pharmacokinetically guided algorithm of 5-fluorouracil dosing, a reliable strategy of precision chemotherapy for solid tumors: a meta-analysis.
Sci Rep. 2016 May 27;6:25913. doi: 10.1038/srep25913.
6
Therapeutic drug monitoring of 5-fluorouracil.
Cancer Chemother Pharmacol. 2016 Sep;78(3):447-64. doi: 10.1007/s00280-016-3054-2. Epub 2016 May 23.
7
'Toxgnostics': an unmet need in cancer medicine.
Nat Rev Cancer. 2014 Jun;14(6):440-5. doi: 10.1038/nrc3729. Epub 2014 May 15.
8
Personalizing colon cancer therapeutics: targeting old and new mechanisms of action.
Pharmaceuticals (Basel). 2013 Aug 21;6(8):988-1038. doi: 10.3390/ph6080988.
9
Pharmacokinetic evaluation of novel oral fluorouracil antitumor drug S-1 in Chinese cancer patients.
Acta Pharmacol Sin. 2013 Apr;34(4):570-80. doi: 10.1038/aps.2012.169. Epub 2013 Feb 11.
10
Anticancer activity of an extract from needles and twigs of Taxus cuspidata and its synergistic effect as a cocktail with 5-fluorouracil.
BMC Complement Altern Med. 2011 Dec 2;11:123. doi: 10.1186/1472-6882-11-123.
本文引用的文献
1
THE PHYSIOLOGIC DISPOSITION OF 5-FLUOROURACIL AND 5-FLUORO-2'-DEOXYURIDINE IN MAN.
Clin Pharmacol Ther. 1964 Sep-Oct;5:581-610. doi: 10.1002/cpt196455581.
2
Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893).
Cancer Chemother Rep. 1974 Sep-Oct;58(5 Pt 1):723-31.
3
Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma.
Cancer. 1975 Jul;36(1):123-8. doi: 10.1002/1097-0142(197507)36:1<123::aid-cncr2820360108>3.0.co;2-c.
4
Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.
J Natl Cancer Inst. 1975 Jan;54(1):69-71. doi: 10.1093/jnci/54.1.69.
5
A double-blind comparison of intensive course 5-flourouracil by oral vs. intravenous route in the treatment of colorectal carcinoma.
Cancer. 1975 Apr;35(4):1031-5. doi: 10.1002/1097-0142(197504)35:4<1031::aid-cncr2820350403>3.0.co;2-n.
6
A sensitive assay of 5-fluorouracil in plasma by gas chromatography-mass spectrometry.
Br J Clin Pharmacol. 1976 Feb;3(1):135-43. doi: 10.1111/j.1365-2125.1976.tb00580.x.
7
Prediction of marrow toxicity in patients treated by intravenous infusion of 5 fluorouracil.
Eur J Cancer (1965). 1977 Jan;13(1):81-7. doi: 10.1016/0014-2964(77)90233-x.
8
Chemotherapy of colorectal carcinoma.
Semin Oncol. 1976 Dec;3(4):415-20.
Zotero 插件